Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen–radioguided Surgery-Reference-Cited by-同舟云学术

Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen–radioguided Surgery

Published:2023-01 Issue:1 Volume:83 Page:62-69
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Knipper Sophie,Mehdi Irai Mehrdad,Simon Ricarda,Koehler Daniel,Rauscher Isabel,Eiber Matthias,van Leeuwen Fijs W.B.,van Leeuwen Pim,de Barros Hilda,van der Poel Henk,Budäus Lars,Steuber Thomas,Graefen Markus,Tennstedt Pierre,Heck Matthias M.,Horn Thomas,Maurer Tobias

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Current use of PSMA-PET in prostate cancer management;Maurer;Nat Rev Urol,2016

2. Diagnostic accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT before salvage lymph node dissection for recurrent prostate cancer;Jilg;Theranostics,2017

3. Detection rate of 18F-choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for prostate cancer lymph node metastases with direct link from PET to histopathology: dependence on the size of tumor deposits in lymph nodes;Jilg;J Nucl Med,2019

4. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

5. Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen-ligand positron-emission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy;Rauscher;Eur Urol,2018

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients;World Journal of Urology;2024-08-12

2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

3. Surgical navigation for targeted retroperitoneal lymph-node removal: a randomised, controlled, phase 3 trial;eClinicalMedicine;2024-08

4. Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review;European Urology Oncology;2024-07

5. The realization of medical devices for precision surgery – development and implementation of ‘ stop-and-go’ imaging technologies;Expert Review of Medical Devices;2024-05-03